Laporan Laba Rugi CLVLY - TTM - Clinuvel Pharmaceuticals Limited - Depositary Receipt (Common Stock)

Laporan Laba Rugi (TTM)

Laporan Laba Rugi Clinuvel Pharmaceuticals Limited - Depositary Receipt (Common Stock) menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

	2020 09-30	2020 12-31	2021 03-31	2021 06-30	2021 09-30	2021 12-31	2022 03-31	2022 06-30	2022 09-30	2022 12-31	2023 03-31	2023 06-30	2023 09-30	2023 12-31	2024 03-31	2024 06-30	2024 09-30	2024 12-31	2025 03-31	2025 06-30
Revenue	35	38	43	48	53	57	62	66	68	70	74	78	80	82	85	88	90	91	93	95
Change (%)		8.14	13.02	11.52	9.41	8.60	7.23	6.75	3.44	3.33	5.75	5.43	2.19	2.15	3.93	3.78	1.61	1.59	2.19	2.15
% of Revenue	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00

Cost Of Sales	8	9	7	4	6	8	8	9	8	7	7	8	7	7	7	8	8	8	8	8
Change (%)		10.07	-26.65	-36.34	41.54	29.35	10.55	9.54	-10.74	-12.04	1.78	1.75	-5.46	-5.77	7.71	7.16	3.98	3.83	0.76	0.76
% of Revenue	22.90	23.31	15.13	8.64	11.17	13.31	13.72	14.08	12.15	10.34	9.95	9.60	8.88	8.20	8.49	8.77	8.97	9.17	9.04	8.92

Gross Operating Profit	27	29	37	44	47	50	53	56	60	63	67	71	73	75	78	80	82	83	85	87
Change (%)		7.57	25.07	20.05	6.38	6.00	6.73	6.30	5.77	5.45	6.20	5.84	3.01	2.92	3.59	3.47	1.39	1.37	2.34	2.28
% of Revenue	77.10	76.69	84.87	91.36	88.83	86.69	86.28	85.92	87.85	89.66	90.05	90.40	91.12	91.80	91.51	91.23	91.03	90.83	90.96	91.08

SG&A	13	14	14	14	16	17	18	19	20	21	23	25	27	29	29	29	28	27	29	32
Change (%)		6.41	0.96	0.95	9.84	8.96	6.47	6.07	4.57	4.37	8.94	8.21	8.64	7.95	0.09	0.09	-3.91	-4.07	10.38	9.40
% of Revenue	36.85	36.26	32.39	29.33	29.44	29.53	29.32	29.14	29.46	29.75	30.65	31.46	33.44	35.34	34.04	32.83	31.05	29.32	31.66	33.91

R&D	-1	-3	-1	1	1	1	1	1	1	1	1	1	1	1	2	2	3	4	6	7
Change (%)		125.75	-59.15	-144.80	18.24	15.42	32.50	24.53	1.07	1.05	0.36	0.36	6.40	6.01	32.07	24.28	44.44	30.77	33.46	25.07
% of Revenue	-3.74	-7.80	-2.82	1.13	1.22	1.30	1.61	1.88	1.83	1.79	1.70	1.62	1.69	1.75	2.22	2.66	3.79	4.87	6.36	7.79

OpEx	20	20	20	20	23	26	28	30	30	30	32	34	36	38	39	40	40	40	45	49
Change (%)		-0.81	-0.59	-0.60	16.41	14.10	7.51	6.99	-0.38	-0.38	7.09	6.62	5.55	5.26	2.13	2.09	0.60	0.59	11.45	10.27
% of Revenue	56.84	52.14	45.86	40.88	43.49	45.69	45.81	45.91	44.22	42.63	43.17	43.66	45.09	46.47	45.66	44.92	44.47	44.03	48.02	51.84

Operating Income	15	18	23	29	30	31	33	36	38	40	42	44	44	44	46	49	50	51	48	46
Change (%)		19.93	27.84	21.78	4.58	4.38	7.00	6.54	6.69	6.27	4.75	4.53	-0.41	-0.41	5.49	5.20	2.44	2.39	-5.09	-5.36
% of Revenue	43.16	47.86	54.14	59.12	56.51	54.31	54.19	54.09	55.78	57.37	56.83	56.34	54.91	53.53	54.34	55.08	55.53	55.97	51.98	48.16

Interest Expense	-2	-3	-2	-2	-2	-2	-2	-2	-2	-3	-3	-3	-4	-4	-4	-4	-4	-4	-4	-4
Change (%)		15.64	-17.41	-30.40	5.34	5.07	5.28	20.61	8.79	8.08	9.69	8.84	11.77	10.53	6.46	6.07	-0.49	-0.49	0.59	0.59
% of Revenue	-6.87	-7.34	-5.37	-3.35	-3.22	-3.12	-3.06	-3.46	-3.64	-3.81	-3.95	-4.08	-4.46	-4.82	-4.94	-5.05	-4.95	-4.85	-4.77	-4.70

Net Income	18	21	23	25	24	24	22	21	24	26	29	31	30	30	33	36	37	39	37	36
Change (%)		16.33	9.08	8.32	-1.25	-1.26	-6.70	-7.19	13.21	11.67	7.97	7.38	-0.74	-0.74	9.09	8.33	4.40	4.22	-3.36	-3.47
% of Revenue	50.74	54.59	52.69	51.18	46.19	41.99	36.54	31.77	34.77	37.58	38.37	39.08	37.95	36.88	38.71	40.41	41.52	42.60	40.29	38.07

Source: Capital IQ

Clinuvel Pharmaceuticals Limited - Depositary Receipt (Common Stock) - Laporan Laba Rugi (TTM)

Laporan Laba Rugi (TTM)

Other Listings